Power Breakthroughs in Healthcare and Life Sciences

Advance Medicine and Research With AI

Healthcare demands new computing paradigms to meet the need for personalized medicine, next-generation clinics, enhanced quality of care, and breakthroughs in biomedical research to treat disease. With NVIDIA, healthcare institutions can harness the power of artificial intelligence (AI) and high-performance computing (HPC) to define the future of medicine.

Read the Latest Healthcare News

BioNeMo Large Language Model

Generative AI Services to Advance Biology Research and Development

NVIDIA is expanding a set of generative AI cloud services for customizing AI foundation models to accelerate the creation of new proteins and therapeutics, as well as research in the fields of genomics, chemistry, biology and molecular dynamics.

Board using large language models for drug discovery

Medtronic and NVIDIA Build AI Platform for Medical Devices

NVIDIA is collaborating with Medtronic, the world’s largest healthcare technology provider, to accelerate the development of AI-enabled medical devices.

NVIDIA IGX Edge AI Computing

First Generative AI Supercomputer for Japan's Pharmaceutical Industry

Mitsui is collaborating with NVIDIA on Tokyo-1—an initiative to supercharge Japan’s pharmaceutical research and development.

NVIDIA IGX Edge AI Computing

Bringing NVIDIA Clara AI to Enterprises Worldwide

Discover how pioneering companies and researchers are building, integrating and adopting NVIDIA Clara software and services to accelerate drug discovery, medical devices, genomics, and imaging.

The Conference for the Era of AI and the Metaverse

Developer Conference March 20-23 | Keynote March 21

Don't miss these upcoming healthcare sessions at GTC.

Accelerating Generative AI in Biology and Healthcare

Generative AI has the potential to accelerate many industries, including biology and healthcare. In this talk, Kimberly Powell, VP/GM of NVIDIA Healthcare and Life Sciences, will explore how the intersection of generative AI with biology and healthcare is driving breakthrough innovations that could help how we diagnose and treat disease. From data to discovery, we'll examine the most recent advancements in generative AI and its current and future implications for biology and healthcare.

A Transformative AI Platform to Accelerate Biologics Discovery

Amgen is dramatically accelerating the pace of R&D through digital innovations in our wet and dry labs. Pre-training large biomolecular language models on proprietary data is a critical part of our overall strategy. NVIDIA's AI drug discovery platform running on DGX has enabled us to move further and faster than would have been possible in any other environment. I'll discuss our high-level approach to the generative design of biologics, the unique challenges associated with therapeutic proteins that necessitate pre-training custom models, and our use of NVIDIA, running on DGX to train those models.

Actionable Insights for Surgical Practice

The da Vinci Surgical System has enabled surgeons to perform over 12 million minimally invasive operations globally, and the robotics platform utilizes robust data about exactly what happens during surgical procedures. Artificial intelligence techniques, including machine learning, can leverage such data to generate actionable insights for surgeons and hospitals, creating valuable feedback to improve the quality and safety of care. Intuitive, in collaboration with NVIDIA, continues to explore the limits of where data and AI can take the art and science of surgery. With better patient outcomes as the target, what tools can we build today to make healthcare smarter tomorrow?

The Developer Conference for the Era of AI and the Metaverse

Conference & Training September 19 - 22 | Keynote September 20

AI is creating new possibilities in healthcare. Advances in computational biology are accelerating every phase of drug discovery, a new generation of software-defined medical devices is enabling real-time sensing, smart hospitals are improving clinical experiences, and accelerated computing is unlocking the human genome for better precision medicine. Get the latest innovations across healthcare at GTC22.

  • The Rise of Transformer AI and Digital Twins in Healthcare

    • Kimberly Powell, Vice President of Healthcare, NVIDIA

    The healthcare industry is generating about one-third of the world’s data. Breakthroughs in AI, accelerated computing, and real-time sensing have created new opportunities for drug discovery and healthcare delivery. Transformer AI models are powering a new era of life sciences, helping researchers encode the structure and function of biology and chemistry, making sense of unstructured patient data, and improving detection and diagnosis in medical imaging.

    View Details >

  • Fireside Chat: Johnson & Johnson’s Hybrid Cloud Computing Strategy to Improve Patient Outcomes

    • Rima Alameddine, Vice President of Enterprise Sales, Healthcare, Life Sciences, and Manufacturing, Americas, NVIDIA
    • Rowena Yeo, Chief Technology Officer and Vice President, Johnson & Johnson
    • Hal Stern, Vice President and Head of Technology, Janssen R&D

    Driving health innovations to improve patient outcomes is at the center of Johnson & Johnson’s Janssen Pharmaceuticals mission. J&J is accelerating the discovery and development of novel therapies using a variety of large-scale computational methods. The rapid adoption of artificial intelligence and data science applied to the exceptional volume and richness of data generated in laboratories have made scientific computing an important tool in research and development. This demand has presented new opportunities for J&J’s shared IT services to support the needs of the organization in various areas, such as large language models in biology, digital pathology, computational chemistry, and digital surgery. We’ll discuss how this hybrid infrastructure enables J&J researchers to drive breakthroughs while using resources efficiently

    View Details >

  • Beyond Buzzwords—the Application of AI in the OR Today and Tomorrow

    • George Murgatroyd, General Manager and VP, Digital Surgery, Surgical Robotics, Medtronic
    • Kimberly Powell, Vice President of Healthcare, NVIDIA

    Artificial intelligence. Machine learning. Robotics and automation. Digital ecosystems. Big data and the cloud. These technologies have incredible potential to advance healthcare for patients around the world. But how are these digital technologies being deployed in today’s operating room, and what impact are they having?

    View Details >

  • New Frontiers in Brain Surgery: The Atlas/NVIDIA Collaboration as a Paradigm for Other Surgical Specialties

    • Aaron Cohen-Gadol, President, Neurosurgical Atlas

    We'll discuss the role of high-level computing and digital twins in transforming surgical subspecialties, specifically neurosurgery. The roles of image segmentation, surgical robotics, and navigation will be explored.

    View Details >


Powering Healthcare Solutions With
Accelerated Computing

Drug Discovery

With accelerated computing, researchers can virtually model millions of molecules and screen hundreds of potential drugs simultaneously, reducing costs and speeding time- to- solution.


Using HPC to accelerate genome analysis in population and cancer genomic studies can help identify rare diseases and bring tailored therapeutics to market faster, advancing the journey to precision medicine.

Medical Devices

AI-powered tools can serve as an extra set of “eyes,” helping clinicians to quickly detect and measure anomalies, uplevel surgeons' skills, enhance image quality, and optimize workflows.

Smart Hospitals

From smart sensors to advanced image processing, AI at the edge can deliver immediate insights to optimize patient care and realize the promise of smart hospitals.

Cambridge-1: Accelerating Health Research

Cambridge-1 is a U.K.-based supercomputer launched by NVIDIA to help advance digital biology, genomics, quantum computing, and AI research, empowering leading U.K. scientists and researchers to collaborate on groundbreaking science.

Discover Trailblazing AI Healthcare Startups

AI healthcare startups are vital to pushing the boundaries of health innovation. The NVIDIA® Inception program nurtures over 1,800 healthcare startups developing cutting-edge, GPU-based tools to optimize operations, enhance diagnostics, and elevate patient care. Learn more about the groundbreaking technology being developed by healthcare startups.

Taking AI to Market

Taking AI to Market

With another $28 million in recent funding, Arterys will further develop their ecosystem of partners and clinical-grade AI solutions on their AI web platform, Arterys Marketplace, bridging the gap between medical researchers and clinicians.

Startup’s Sensors Keep Hospitals Safe

Startup’s Sensors Keep Hospitals Safe

With 800 GPU-powered cameras deployed across Northwestern’s 10 hospitals, Artisight aids hospital staff in conducting remote thermal screenings, limiting staff exposure to COVID-19.

AI Helps Triage Patients with COVID-19 Symptoms

AI Helps Triage Patients With COVID-19 Symptoms

AI startup Lunit and their CE-marked solution, Lunit INSIGHT CXR, uses AI to quickly detect 10 different radiological findings on chest X-rays, including pneumonia, often present in COVID-19 patients, and potentially cancerous lung nodules in seconds.

Healthcare Computing From Data Center to Edge to Cloud

Powerful Computing for Data Centers

Powerful Computing for Data Centers

Built with NVIDIA A100 Tensor Core GPUs, the NVIDIA DGX™ A100 system delivers unprecedented compute performance to aid in the discovery of new drugs, uncover genetic mutations to better fight disease, and drive healthcare innovation. Combined with access to experts and easy-to-deploy infrastructure, NVIDIA DGX A100 is the foundational building block in constructing AI data centers.

Real-Time AI at the Edge

Real-Time AI at the Edge

NVIDIA’s edge solutions are designed to gather and process continuous streams of data at the network’s edge. With advanced image, video, and signal processing, AI-embedded medical instruments can aid surgeons in performing less invasive surgeries, support radiologists in determining diagnoses, and assist sonographers in performing fast and accurate echocardiograms. Bring healthcare to the edge with the NVIDIA EGX platform.

AI-Ready Hospital Data Center

AI-Ready Hospital Data Center

The AI Enterprise-Ready Platform from NVIDIA and VMware offers a full-stack architecture for today’s converging solutions. Built for resilience and scale, it provides a single platform for both core hospital applications and AI tools, helping deliver a better experience to clinicians and the patients they serve.

On-Demand Cloud Computing

On-Demand Cloud Computing

The latest NVIDIA GPUs are available through all major cloud platforms worldwide. With simplified IT management, compute that can be increased or reduced as needed,  and access to NVIDIA NGC™ – a hub of GPU-optimized software for deep learning, machine learning, and HPC—organizations can focus on building solutions, gathering insights, and delivering business value.

NVIDIA Partners for Healthcare

NVIDIA solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products, and services.

Stay up to date with the latest healthcare news from NVIDIA.